Business Description
Biogen Inc (Biogen) discovers, develops, and delivers drugs for the treatment of serious neurological and neurodegenerative diseases, including multiple sclerosis (MS) and neuroimmunology; Alzheimer’s disease and dementia; movement disorders and neuromuscular disorders such as spinal muscular atrophy and amyotrophic lateral sclerosis; ophthalmology; pain; neuropsychiatry; and acute neurology. It also manufactures and commercializes biosimilars of advanced biologics.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Biogen conducts R&D to provide innovative products in the areas of MS and neuroimmunology, Alzheimer's disease and dementia, Parkinson's disease and movement disorders, neuromuscular diseases, pain, ophthalmology, acute neurology, idiopathic pulmonary fibrosis, and systemic lupus erythematosus. The company’s pipeline products include Aducanumab, Mosunetuzumab, BAN2401, BIIB092, BIIB076, BIIB080, BIIB054, BIIB067, BIIB074, and BIIB093, Lecanemab, SB15, Dapirolizumab pegol, BIIB059, BIIB125, BIIB800, BIIB104, BIIB124, BIIB131, Orelabrutinib, BIIB061, BIIB076, BIIB091, BIIB094, BIIB100, BIIB101, BIIB107, BIIB110, BIIB118, BIIB121 and BIIB122 The company spent US$2,501.2 million on its R&D activities in FY2021. The company holds several US and Europe patents and patent applications, and a number of corresponding foreign counterparts, related to Avonex, Plegridy, Tecfidera, Tysabri, Fampyra, Zinbryta and Spinraza.
Product Categories
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers products for the treatment of severe rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, moderate to severe plaque psoriasis, paediatric crohn's disease, moderate to severe crohn's disease, severe ulcerative colitis and severe ankylosing spondylitis. - Key products include Benepali, Flixabi and Imraldi.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Develops, manufactures and markets several products to treat patients with MS across the US, Canada, France, Germany, Italy, Japan, Spain and the UK. - Key products include Avonex, Tysabri, Tecfidera, Fumarate, Interferon, Fampyra and Plegridy. Views agreements and collaborations are major growth drivers for the category.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers medicines for severe plaque psoriasis. - Key product includes Fumaderm.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers products for the treatment of SMA. - Key product includes Spinraza.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer